4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tycoon Group Holdings Limited (3390) operates in the Pharmaceutical Retailers industry and is headquartered in Sha Tin, Hong Kong with about 175 employees. Its market capitalization is roughly HKD 213 million. In the fiscal year ended 2025-12-31, 3390 reported HKD 1.1B in revenue and HKD 16M in net income.
Tycoon Group Holdings Limited, an investment holding company, distributes and retails a range of health and well-being related products in Mainland China, Hong Kong, Macau, Singapore, Malaysia, and internationally. The company operates through Distribution, E-Commerce, and Retail Store segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HKD 1.1B | HKD 876M | HKD 1.2B | HKD 1.2B | — |
| Gross Profit | HKD 270M | HKD 233M | HKD 321M | HKD 262M | — |
| Operating Income (EBIT) | HKD 39M | HKD 28M | HKD 129M | HKD 69M | — |
| Net Income | HKD 16M | HKD 3M | HKD 297M | HKD 44M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | (HKD 28M) | (HKD 52M) | — | (HKD 16M) |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 1.2B | HKD 1.0B | HKD 989M | HKD 1.0B | — |
| Total Liabilities | HKD 625M | HKD 517M | HKD 445M | HKD 719M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3390 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms